mutations and types
mutations types classification genetic
| Type | Description | Example |
|---|---|---|
| Point mutation | Single nucleotide change | Sickle cell disease (GAG→GTG) |
| Small insertions/deletions (indels) | Addition or removal of a few bases | Frameshift mutations |
| Structural variants | Large-scale rearrangements | Inversions, translocations |
| Copy Number Variants (CNVs) | Duplication or deletion of large segments | DiGeorge syndrome (22q11 deletion) |
| Aneuploidies | Whole chromosome gain/loss | Trisomy 21 (Down syndrome) |
| Type | Definition | Example |
|---|---|---|
| Substitution | One base replaced by another | Most SNPs |
| — Transition | Purine↔Purine or Pyrimidine↔Pyrimidine (A↔G, C↔T) | Common in aging |
| — Transversion | Purine↔Pyrimidine (A/G↔C/T) | UV-induced mutations |
| Insertion | Addition of one or more bases | Causes frameshifts |
| Deletion | Removal of one or more bases | Causes frameshifts |
| Inversion | Segment reversed within chromosome | Hemophilia A |
| Translocation | Segment moved to another chromosome | CML (Philadelphia chromosome) |
| Duplication | Segment duplicated | Charcot-Marie-Tooth disease |
| Type | Effect | Example |
|---|---|---|
| Silent (synonymous) | No amino acid change (due to codon degeneracy) | — |
| Missense | Single amino acid change | HbS in sickle cell disease |
| Nonsense | Creates a premature stop codon → truncated protein | Duchenne muscular dystrophy |
| Frameshift | Shifts reading frame → garbled protein | Tay-Sachs disease |
| Splice-site | Disrupts mRNA splicing → exon skipping/intron retention | β-Thalassemia |
| Regulatory/promoter | Alters gene expression level | β-Thalassemia (some forms) |
| Trinucleotide repeat expansion | Expansion of repetitive sequences | Huntington's disease, Fragile X |
| Type | Definition |
|---|---|
| Germline mutation | Inherited; present in every cell; passed to offspring |
| Somatic mutation | Acquired in non-germ cells; affects only certain tissues; not heritable |
| De novo mutation | New mutation not present in parents; accounts for many dominant diseases |
| Type | Mechanism | Example |
|---|---|---|
| Loss-of-function (LOF) | Reduces/eliminates protein activity; often recessive | CFTR mutations in cystic fibrosis |
| Gain-of-function (GOF) | Confers new/enhanced activity; often dominant | RAS mutations in cancer |
| Dominant negative | Mutant protein interferes with wild-type | Some collagen mutations in OI |
| Haploinsufficiency | Single functional copy insufficient | BRCA1 mutations |